nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA6—submandibular gland—head and neck cancer	0.0686	0.217	CbGeAlD
Topiramate—CA6—saliva—head and neck cancer	0.0247	0.0782	CbGeAlD
Topiramate—CA6—ear—head and neck cancer	0.0226	0.0715	CbGeAlD
Topiramate—CA6—exocrine gland—head and neck cancer	0.0125	0.0395	CbGeAlD
Topiramate—CA6—hair follicle—head and neck cancer	0.0119	0.0377	CbGeAlD
Topiramate—GRIK4—head—head and neck cancer	0.0098	0.031	CbGeAlD
Topiramate—CA6—mouth—head and neck cancer	0.00934	0.0296	CbGeAlD
Topiramate—GRIK5—thyroid gland—head and neck cancer	0.00806	0.0255	CbGeAlD
Topiramate—GRIA4—head—head and neck cancer	0.00774	0.0245	CbGeAlD
Topiramate—GRIK3—head—head and neck cancer	0.00715	0.0226	CbGeAlD
Topiramate—GRIK5—head—head and neck cancer	0.00715	0.0226	CbGeAlD
Topiramate—GRIK1—head—head and neck cancer	0.00679	0.0215	CbGeAlD
Topiramate—CA6—parotid gland—head and neck cancer	0.0065	0.0206	CbGeAlD
Topiramate—GRIA3—head—head and neck cancer	0.00631	0.02	CbGeAlD
Topiramate—CA6—saliva-secreting gland—head and neck cancer	0.00623	0.0197	CbGeAlD
Topiramate—GRIK5—lymph node—head and neck cancer	0.005	0.0158	CbGeAlD
Topiramate—GRIK3—lymph node—head and neck cancer	0.005	0.0158	CbGeAlD
Topiramate—CA7—trachea—head and neck cancer	0.00496	0.0157	CbGeAlD
Topiramate—CA2—exocrine gland—head and neck cancer	0.0043	0.0136	CbGeAlD
Topiramate—CA2—hair follicle—head and neck cancer	0.0041	0.013	CbGeAlD
Topiramate—CA12—connective tissue—head and neck cancer	0.00384	0.0121	CbGeAlD
Topiramate—CA6—head—head and neck cancer	0.00337	0.0107	CbGeAlD
Topiramate—GRIA1—head—head and neck cancer	0.00337	0.0107	CbGeAlD
Topiramate—CA4—neck—head and neck cancer	0.00331	0.0105	CbGeAlD
Topiramate—CA12—trachea—head and neck cancer	0.00322	0.0102	CbGeAlD
Topiramate—CA2—mouth—head and neck cancer	0.00321	0.0102	CbGeAlD
Topiramate—CA2—neck—head and neck cancer	0.00275	0.0087	CbGeAlD
Topiramate—CA4—parotid gland—head and neck cancer	0.0027	0.00855	CbGeAlD
Topiramate—GRIA2—head—head and neck cancer	0.00268	0.00848	CbGeAlD
Topiramate—CA4—saliva-secreting gland—head and neck cancer	0.00259	0.00819	CbGeAlD
Topiramate—SCN1A—head—head and neck cancer	0.00244	0.00774	CbGeAlD
Topiramate—GRIK2—head—head and neck cancer	0.00242	0.00766	CbGeAlD
Topiramate—CA5B—thyroid gland—head and neck cancer	0.00229	0.00724	CbGeAlD
Topiramate—CA12—head—head and neck cancer	0.00226	0.00716	CbGeAlD
Topiramate—CA2—parotid gland—head and neck cancer	0.00224	0.00709	CbGeAlD
Topiramate—CA1—lymphoid tissue—head and neck cancer	0.00222	0.00704	CbGeAlD
Topiramate—CA2—saliva-secreting gland—head and neck cancer	0.00214	0.00679	CbGeAlD
Topiramate—CA5B—head—head and neck cancer	0.00203	0.00642	CbGeAlD
Topiramate—CA4—trachea—head and neck cancer	0.00199	0.00631	CbGeAlD
Topiramate—Stomatitis—Hydroxyurea—head and neck cancer	0.00198	0.00349	CcSEcCtD
Topiramate—CA2—connective tissue—head and neck cancer	0.00197	0.00624	CbGeAlD
Topiramate—Bone pain—Docetaxel—head and neck cancer	0.00197	0.00347	CcSEcCtD
Topiramate—SCN5A—head—head and neck cancer	0.00196	0.00622	CbGeAlD
Topiramate—Lethargy—Fluorouracil—head and neck cancer	0.00193	0.00341	CcSEcCtD
Topiramate—GABRB2—head—head and neck cancer	0.0019	0.00603	CbGeAlD
Topiramate—GABRG2—head—head and neck cancer	0.0019	0.00603	CbGeAlD
Topiramate—Osteoarthritis—Fluorouracil—head and neck cancer	0.00189	0.00334	CcSEcCtD
Topiramate—Pulmonary embolism—Docetaxel—head and neck cancer	0.00188	0.00332	CcSEcCtD
Topiramate—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00188	0.00332	CcSEcCtD
Topiramate—CA2—epithelium—head and neck cancer	0.00187	0.00592	CbGeAlD
Topiramate—Haemoglobin—Hydroxyurea—head and neck cancer	0.00183	0.00323	CcSEcCtD
Topiramate—Influenza like illness—Docetaxel—head and neck cancer	0.00183	0.00323	CcSEcCtD
Topiramate—Haemorrhage—Hydroxyurea—head and neck cancer	0.00182	0.00321	CcSEcCtD
Topiramate—Hallucination—Hydroxyurea—head and neck cancer	0.00181	0.0032	CcSEcCtD
Topiramate—Irritability—Fluorouracil—head and neck cancer	0.00181	0.00319	CcSEcCtD
Topiramate—Candida infection—Docetaxel—head and neck cancer	0.0018	0.00317	CcSEcCtD
Topiramate—CA1—head—head and neck cancer	0.00179	0.00567	CbGeAlD
Topiramate—Fluid retention—Docetaxel—head and neck cancer	0.00179	0.00316	CcSEcCtD
Topiramate—Ataxia—Fluorouracil—head and neck cancer	0.00178	0.00314	CcSEcCtD
Topiramate—Neuropathy—Docetaxel—head and neck cancer	0.00177	0.00312	CcSEcCtD
Topiramate—Alopecia—Vinblastine—head and neck cancer	0.00176	0.00311	CcSEcCtD
Topiramate—Oesophagitis—Docetaxel—head and neck cancer	0.00172	0.00304	CcSEcCtD
Topiramate—Neoplasm—Docetaxel—head and neck cancer	0.0017	0.003	CcSEcCtD
Topiramate—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00169	0.00299	CcSEcCtD
Topiramate—GABRA1—head—head and neck cancer	0.00168	0.00532	CbGeAlD
Topiramate—Muscular weakness—Fluorouracil—head and neck cancer	0.00167	0.00295	CcSEcCtD
Topiramate—CA2—trachea—head and neck cancer	0.00165	0.00524	CbGeAlD
Topiramate—Angiopathy—Hydroxyurea—head and neck cancer	0.00165	0.00291	CcSEcCtD
Topiramate—Dysphagia—Fluorouracil—head and neck cancer	0.00164	0.00289	CcSEcCtD
Topiramate—Chills—Hydroxyurea—head and neck cancer	0.00163	0.00288	CcSEcCtD
Topiramate—Eosinophilia—Fluorouracil—head and neck cancer	0.00162	0.00286	CcSEcCtD
Topiramate—Ill-defined disorder—Vinblastine—head and neck cancer	0.00161	0.00285	CcSEcCtD
Topiramate—Alopecia—Hydroxyurea—head and neck cancer	0.00161	0.00284	CcSEcCtD
Topiramate—Anaemia—Vinblastine—head and neck cancer	0.00161	0.00283	CcSEcCtD
Topiramate—Angina pectoris—Fluorouracil—head and neck cancer	0.0016	0.00281	CcSEcCtD
Topiramate—Phlebitis—Docetaxel—head and neck cancer	0.00159	0.0028	CcSEcCtD
Topiramate—Erythema—Hydroxyurea—head and neck cancer	0.00159	0.0028	CcSEcCtD
Topiramate—CA4—thyroid gland—head and neck cancer	0.00158	0.005	CbGeAlD
Topiramate—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00157	0.00277	CcSEcCtD
Topiramate—Malaise—Vinblastine—head and neck cancer	0.00157	0.00277	CcSEcCtD
Topiramate—Vertigo—Vinblastine—head and neck cancer	0.00156	0.00276	CcSEcCtD
Topiramate—Leukopenia—Vinblastine—head and neck cancer	0.00156	0.00275	CcSEcCtD
Topiramate—Pancytopenia—Fluorouracil—head and neck cancer	0.00156	0.00274	CcSEcCtD
Topiramate—Deafness—Docetaxel—head and neck cancer	0.00153	0.0027	CcSEcCtD
Topiramate—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00152	0.00269	CcSEcCtD
Topiramate—Hepatic failure—Docetaxel—head and neck cancer	0.00152	0.00268	CcSEcCtD
Topiramate—Convulsion—Vinblastine—head and neck cancer	0.00151	0.00266	CcSEcCtD
Topiramate—Hypertension—Vinblastine—head and neck cancer	0.0015	0.00265	CcSEcCtD
Topiramate—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00149	0.00264	CcSEcCtD
Topiramate—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00147	0.00259	CcSEcCtD
Topiramate—Pneumonia—Fluorouracil—head and neck cancer	0.00147	0.00259	CcSEcCtD
Topiramate—Anaemia—Hydroxyurea—head and neck cancer	0.00147	0.00258	CcSEcCtD
Topiramate—Discomfort—Vinblastine—head and neck cancer	0.00146	0.00258	CcSEcCtD
Topiramate—Hot flush—Docetaxel—head and neck cancer	0.00146	0.00258	CcSEcCtD
Topiramate—Infestation—Fluorouracil—head and neck cancer	0.00146	0.00258	CcSEcCtD
Topiramate—Infestation NOS—Fluorouracil—head and neck cancer	0.00146	0.00258	CcSEcCtD
Topiramate—Menopausal symptoms—Docetaxel—head and neck cancer	0.00145	0.00256	CcSEcCtD
Topiramate—Visual disturbance—Docetaxel—head and neck cancer	0.00144	0.00255	CcSEcCtD
Topiramate—CA2—lymphoid tissue—head and neck cancer	0.00144	0.00456	CbGeAlD
Topiramate—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00143	0.00253	CcSEcCtD
Topiramate—Malaise—Hydroxyurea—head and neck cancer	0.00143	0.00252	CcSEcCtD
Topiramate—Stomatitis—Fluorouracil—head and neck cancer	0.00142	0.00251	CcSEcCtD
Topiramate—CA5B—lymph node—head and neck cancer	0.00142	0.0045	CbGeAlD
Topiramate—Conjunctivitis—Fluorouracil—head and neck cancer	0.00142	0.0025	CcSEcCtD
Topiramate—Urinary tract infection—Fluorouracil—head and neck cancer	0.00142	0.0025	CcSEcCtD
Topiramate—Leukopenia—Hydroxyurea—head and neck cancer	0.00142	0.0025	CcSEcCtD
Topiramate—CA4—head—head and neck cancer	0.0014	0.00443	CbGeAlD
Topiramate—Lethargy—Docetaxel—head and neck cancer	0.0014	0.00246	CcSEcCtD
Topiramate—Thrombocytopenia—Vinblastine—head and neck cancer	0.00139	0.00245	CcSEcCtD
Topiramate—Epistaxis—Fluorouracil—head and neck cancer	0.00138	0.00243	CcSEcCtD
Topiramate—Convulsion—Hydroxyurea—head and neck cancer	0.00137	0.00242	CcSEcCtD
Topiramate—Hyponatraemia—Docetaxel—head and neck cancer	0.00137	0.00242	CcSEcCtD
Topiramate—Sinusitis—Fluorouracil—head and neck cancer	0.00137	0.00242	CcSEcCtD
Topiramate—Pain in extremity—Docetaxel—head and neck cancer	0.00137	0.00241	CcSEcCtD
Topiramate—Agranulocytosis—Fluorouracil—head and neck cancer	0.00136	0.0024	CcSEcCtD
Topiramate—Anorexia—Vinblastine—head and neck cancer	0.00135	0.00239	CcSEcCtD
Topiramate—Migraine—Docetaxel—head and neck cancer	0.00135	0.00237	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00134	0.00236	CcSEcCtD
Topiramate—Discomfort—Hydroxyurea—head and neck cancer	0.00133	0.00235	CcSEcCtD
Topiramate—Haemoglobin—Fluorouracil—head and neck cancer	0.00132	0.00232	CcSEcCtD
Topiramate—Rhinitis—Fluorouracil—head and neck cancer	0.00131	0.00232	CcSEcCtD
Topiramate—Haemorrhage—Fluorouracil—head and neck cancer	0.00131	0.00231	CcSEcCtD
Topiramate—CA2—thyroid gland—head and neck cancer	0.00131	0.00414	CbGeAlD
Topiramate—Hypoaesthesia—Fluorouracil—head and neck cancer	0.0013	0.0023	CcSEcCtD
Topiramate—Pharyngitis—Fluorouracil—head and neck cancer	0.0013	0.0023	CcSEcCtD
Topiramate—Oedema—Hydroxyurea—head and neck cancer	0.00129	0.00228	CcSEcCtD
Topiramate—Ataxia—Docetaxel—head and neck cancer	0.00129	0.00227	CcSEcCtD
Topiramate—Infection—Hydroxyurea—head and neck cancer	0.00129	0.00227	CcSEcCtD
Topiramate—Paraesthesia—Vinblastine—head and neck cancer	0.00127	0.00225	CcSEcCtD
Topiramate—Dehydration—Docetaxel—head and neck cancer	0.00127	0.00224	CcSEcCtD
Topiramate—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00127	0.00224	CcSEcCtD
Topiramate—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00127	0.00223	CcSEcCtD
Topiramate—Liver function test abnormal—Docetaxel—head and neck cancer	0.00126	0.00223	CcSEcCtD
Topiramate—Skin disorder—Hydroxyurea—head and neck cancer	0.00126	0.00222	CcSEcCtD
Topiramate—CA1—lymph node—head and neck cancer	0.00125	0.00397	CbGeAlD
Topiramate—Abdominal pain upper—Docetaxel—head and neck cancer	0.00125	0.0022	CcSEcCtD
Topiramate—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00125	0.0022	CcSEcCtD
Topiramate—Breast disorder—Docetaxel—head and neck cancer	0.00124	0.00218	CcSEcCtD
Topiramate—Anorexia—Hydroxyurea—head and neck cancer	0.00123	0.00218	CcSEcCtD
Topiramate—Decreased appetite—Vinblastine—head and neck cancer	0.00123	0.00218	CcSEcCtD
Topiramate—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00123	0.00217	CcSEcCtD
Topiramate—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00123	0.00217	CcSEcCtD
Topiramate—Nasopharyngitis—Docetaxel—head and neck cancer	0.00122	0.00216	CcSEcCtD
Topiramate—Constipation—Vinblastine—head and neck cancer	0.00121	0.00214	CcSEcCtD
Topiramate—Pain—Vinblastine—head and neck cancer	0.00121	0.00214	CcSEcCtD
Topiramate—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00121	0.00213	CcSEcCtD
Topiramate—Dysphagia—Docetaxel—head and neck cancer	0.00118	0.00209	CcSEcCtD
Topiramate—Feeling abnormal—Vinblastine—head and neck cancer	0.00117	0.00206	CcSEcCtD
Topiramate—CA2—head—head and neck cancer	0.00116	0.00367	CbGeAlD
Topiramate—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00116	0.00205	CcSEcCtD
Topiramate—Alopecia—Fluorouracil—head and neck cancer	0.00116	0.00204	CcSEcCtD
Topiramate—Dyspnoea—Hydroxyurea—head and neck cancer	0.00115	0.00203	CcSEcCtD
Topiramate—Angina pectoris—Docetaxel—head and neck cancer	0.00115	0.00203	CcSEcCtD
Topiramate—Somnolence—Hydroxyurea—head and neck cancer	0.00115	0.00203	CcSEcCtD
Topiramate—Erythema—Fluorouracil—head and neck cancer	0.00114	0.00201	CcSEcCtD
Topiramate—Dyspepsia—Hydroxyurea—head and neck cancer	0.00114	0.00201	CcSEcCtD
Topiramate—Decreased appetite—Hydroxyurea—head and neck cancer	0.00112	0.00198	CcSEcCtD
Topiramate—Pancytopenia—Docetaxel—head and neck cancer	0.00112	0.00198	CcSEcCtD
Topiramate—Abdominal pain—Vinblastine—head and neck cancer	0.00112	0.00198	CcSEcCtD
Topiramate—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00112	0.00197	CcSEcCtD
Topiramate—Fatigue—Hydroxyurea—head and neck cancer	0.00112	0.00197	CcSEcCtD
Topiramate—Pain—Hydroxyurea—head and neck cancer	0.00111	0.00195	CcSEcCtD
Topiramate—Constipation—Hydroxyurea—head and neck cancer	0.00111	0.00195	CcSEcCtD
Topiramate—Neutropenia—Docetaxel—head and neck cancer	0.00111	0.00195	CcSEcCtD
Topiramate—Weight increased—Docetaxel—head and neck cancer	0.00108	0.0019	CcSEcCtD
Topiramate—Vision blurred—Fluorouracil—head and neck cancer	0.00108	0.0019	CcSEcCtD
Topiramate—Weight decreased—Docetaxel—head and neck cancer	0.00107	0.00189	CcSEcCtD
Topiramate—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00107	0.00188	CcSEcCtD
Topiramate—Pneumonia—Docetaxel—head and neck cancer	0.00106	0.00187	CcSEcCtD
Topiramate—Anaemia—Fluorouracil—head and neck cancer	0.00105	0.00186	CcSEcCtD
Topiramate—Infestation NOS—Docetaxel—head and neck cancer	0.00105	0.00186	CcSEcCtD
Topiramate—Infestation—Docetaxel—head and neck cancer	0.00105	0.00186	CcSEcCtD
Topiramate—Hypersensitivity—Vinblastine—head and neck cancer	0.00105	0.00184	CcSEcCtD
Topiramate—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00104	0.00184	CcSEcCtD
Topiramate—Renal failure—Docetaxel—head and neck cancer	0.00104	0.00183	CcSEcCtD
Topiramate—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00103	0.00182	CcSEcCtD
Topiramate—Stomatitis—Docetaxel—head and neck cancer	0.00103	0.00181	CcSEcCtD
Topiramate—Conjunctivitis—Docetaxel—head and neck cancer	0.00102	0.00181	CcSEcCtD
Topiramate—Body temperature increased—Hydroxyurea—head and neck cancer	0.00102	0.0018	CcSEcCtD
Topiramate—Leukopenia—Fluorouracil—head and neck cancer	0.00102	0.0018	CcSEcCtD
Topiramate—Asthenia—Vinblastine—head and neck cancer	0.00102	0.0018	CcSEcCtD
Topiramate—Epistaxis—Docetaxel—head and neck cancer	0.000994	0.00175	CcSEcCtD
Topiramate—Convulsion—Fluorouracil—head and neck cancer	0.000989	0.00174	CcSEcCtD
Topiramate—Agranulocytosis—Docetaxel—head and neck cancer	0.000984	0.00174	CcSEcCtD
Topiramate—CA4—lymph node—head and neck cancer	0.00098	0.0031	CbGeAlD
Topiramate—Chest pain—Fluorouracil—head and neck cancer	0.000972	0.00171	CcSEcCtD
Topiramate—Myalgia—Fluorouracil—head and neck cancer	0.000972	0.00171	CcSEcCtD
Topiramate—Diarrhoea—Vinblastine—head and neck cancer	0.000971	0.00171	CcSEcCtD
Topiramate—Discomfort—Fluorouracil—head and neck cancer	0.00096	0.00169	CcSEcCtD
Topiramate—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000953	0.00168	CcSEcCtD
Topiramate—Haemoglobin—Docetaxel—head and neck cancer	0.000951	0.00168	CcSEcCtD
Topiramate—Rhinitis—Docetaxel—head and neck cancer	0.000949	0.00167	CcSEcCtD
Topiramate—Haemorrhage—Docetaxel—head and neck cancer	0.000946	0.00167	CcSEcCtD
Topiramate—Hepatitis—Docetaxel—head and neck cancer	0.000946	0.00167	CcSEcCtD
Topiramate—Hypoaesthesia—Docetaxel—head and neck cancer	0.000941	0.00166	CcSEcCtD
Topiramate—Confusional state—Fluorouracil—head and neck cancer	0.000939	0.00166	CcSEcCtD
Topiramate—Pharyngitis—Docetaxel—head and neck cancer	0.000939	0.00166	CcSEcCtD
Topiramate—Dizziness—Vinblastine—head and neck cancer	0.000938	0.00166	CcSEcCtD
Topiramate—Urinary tract disorder—Docetaxel—head and neck cancer	0.000934	0.00165	CcSEcCtD
Topiramate—Oedema peripheral—Docetaxel—head and neck cancer	0.000932	0.00164	CcSEcCtD
Topiramate—Oedema—Fluorouracil—head and neck cancer	0.000931	0.00164	CcSEcCtD
Topiramate—Connective tissue disorder—Docetaxel—head and neck cancer	0.00093	0.00164	CcSEcCtD
Topiramate—Asthenia—Hydroxyurea—head and neck cancer	0.000928	0.00164	CcSEcCtD
Topiramate—Urethral disorder—Docetaxel—head and neck cancer	0.000927	0.00164	CcSEcCtD
Topiramate—Infection—Fluorouracil—head and neck cancer	0.000925	0.00163	CcSEcCtD
Topiramate—Nervous system disorder—Fluorouracil—head and neck cancer	0.000913	0.00161	CcSEcCtD
Topiramate—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000912	0.00161	CcSEcCtD
Topiramate—Visual impairment—Docetaxel—head and neck cancer	0.000912	0.00161	CcSEcCtD
Topiramate—Tachycardia—Fluorouracil—head and neck cancer	0.000909	0.0016	CcSEcCtD
Topiramate—Vomiting—Vinblastine—head and neck cancer	0.000902	0.00159	CcSEcCtD
Topiramate—Erythema multiforme—Docetaxel—head and neck cancer	0.000895	0.00158	CcSEcCtD
Topiramate—Headache—Vinblastine—head and neck cancer	0.000889	0.00157	CcSEcCtD
Topiramate—Anorexia—Fluorouracil—head and neck cancer	0.000888	0.00157	CcSEcCtD
Topiramate—Diarrhoea—Hydroxyurea—head and neck cancer	0.000885	0.00156	CcSEcCtD
Topiramate—Eye disorder—Docetaxel—head and neck cancer	0.000884	0.00156	CcSEcCtD
Topiramate—Cardiac disorder—Docetaxel—head and neck cancer	0.000878	0.00155	CcSEcCtD
Topiramate—Flushing—Docetaxel—head and neck cancer	0.000878	0.00155	CcSEcCtD
Topiramate—Hypotension—Fluorouracil—head and neck cancer	0.00087	0.00154	CcSEcCtD
Topiramate—Angiopathy—Docetaxel—head and neck cancer	0.000858	0.00151	CcSEcCtD
Topiramate—Dizziness—Hydroxyurea—head and neck cancer	0.000856	0.00151	CcSEcCtD
Topiramate—Immune system disorder—Docetaxel—head and neck cancer	0.000855	0.00151	CcSEcCtD
Topiramate—Mediastinal disorder—Docetaxel—head and neck cancer	0.000853	0.0015	CcSEcCtD
Topiramate—Chills—Docetaxel—head and neck cancer	0.000849	0.0015	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000849	0.0015	CcSEcCtD
Topiramate—Nausea—Vinblastine—head and neck cancer	0.000843	0.00149	CcSEcCtD
Topiramate—Insomnia—Fluorouracil—head and neck cancer	0.000842	0.00149	CcSEcCtD
Topiramate—Paraesthesia—Fluorouracil—head and neck cancer	0.000836	0.00148	CcSEcCtD
Topiramate—Alopecia—Docetaxel—head and neck cancer	0.000836	0.00147	CcSEcCtD
Topiramate—Dyspnoea—Fluorouracil—head and neck cancer	0.00083	0.00146	CcSEcCtD
Topiramate—Mental disorder—Docetaxel—head and neck cancer	0.000829	0.00146	CcSEcCtD
Topiramate—Somnolence—Fluorouracil—head and neck cancer	0.000828	0.00146	CcSEcCtD
Topiramate—Erythema—Docetaxel—head and neck cancer	0.000824	0.00145	CcSEcCtD
Topiramate—Malnutrition—Docetaxel—head and neck cancer	0.000824	0.00145	CcSEcCtD
Topiramate—Vomiting—Hydroxyurea—head and neck cancer	0.000823	0.00145	CcSEcCtD
Topiramate—Dyspepsia—Fluorouracil—head and neck cancer	0.00082	0.00145	CcSEcCtD
Topiramate—Rash—Hydroxyurea—head and neck cancer	0.000816	0.00144	CcSEcCtD
Topiramate—Dermatitis—Hydroxyurea—head and neck cancer	0.000815	0.00144	CcSEcCtD
Topiramate—CA2—lymph node—head and neck cancer	0.000813	0.00257	CbGeAlD
Topiramate—Headache—Hydroxyurea—head and neck cancer	0.000811	0.00143	CcSEcCtD
Topiramate—Decreased appetite—Fluorouracil—head and neck cancer	0.00081	0.00143	CcSEcCtD
Topiramate—Dysgeusia—Docetaxel—head and neck cancer	0.000807	0.00142	CcSEcCtD
Topiramate—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000804	0.00142	CcSEcCtD
Topiramate—Back pain—Docetaxel—head and neck cancer	0.000797	0.00141	CcSEcCtD
Topiramate—Pain—Fluorouracil—head and neck cancer	0.000796	0.0014	CcSEcCtD
Topiramate—Muscle spasms—Docetaxel—head and neck cancer	0.000792	0.0014	CcSEcCtD
Topiramate—Nausea—Hydroxyurea—head and neck cancer	0.000769	0.00136	CcSEcCtD
Topiramate—Feeling abnormal—Fluorouracil—head and neck cancer	0.000767	0.00135	CcSEcCtD
Topiramate—Anaemia—Docetaxel—head and neck cancer	0.000761	0.00134	CcSEcCtD
Topiramate—Urticaria—Fluorouracil—head and neck cancer	0.00074	0.00131	CcSEcCtD
Topiramate—Syncope—Docetaxel—head and neck cancer	0.000739	0.0013	CcSEcCtD
Topiramate—Leukopenia—Docetaxel—head and neck cancer	0.000737	0.0013	CcSEcCtD
Topiramate—Body temperature increased—Fluorouracil—head and neck cancer	0.000736	0.0013	CcSEcCtD
Topiramate—Palpitations—Docetaxel—head and neck cancer	0.000728	0.00128	CcSEcCtD
Topiramate—Loss of consciousness—Docetaxel—head and neck cancer	0.000724	0.00128	CcSEcCtD
Topiramate—Cough—Docetaxel—head and neck cancer	0.000719	0.00127	CcSEcCtD
Topiramate—Convulsion—Docetaxel—head and neck cancer	0.000714	0.00126	CcSEcCtD
Topiramate—Hypertension—Docetaxel—head and neck cancer	0.000711	0.00125	CcSEcCtD
Topiramate—Arthralgia—Docetaxel—head and neck cancer	0.000701	0.00124	CcSEcCtD
Topiramate—Myalgia—Docetaxel—head and neck cancer	0.000701	0.00124	CcSEcCtD
Topiramate—Chest pain—Docetaxel—head and neck cancer	0.000701	0.00124	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000696	0.00123	CcSEcCtD
Topiramate—Hypersensitivity—Fluorouracil—head and neck cancer	0.000686	0.00121	CcSEcCtD
Topiramate—Dry mouth—Docetaxel—head and neck cancer	0.000686	0.00121	CcSEcCtD
Topiramate—Confusional state—Docetaxel—head and neck cancer	0.000678	0.0012	CcSEcCtD
Topiramate—Oedema—Docetaxel—head and neck cancer	0.000672	0.00119	CcSEcCtD
Topiramate—Infection—Docetaxel—head and neck cancer	0.000668	0.00118	CcSEcCtD
Topiramate—Shock—Docetaxel—head and neck cancer	0.000661	0.00117	CcSEcCtD
Topiramate—Nervous system disorder—Docetaxel—head and neck cancer	0.000659	0.00116	CcSEcCtD
Topiramate—Pruritus—Fluorouracil—head and neck cancer	0.000659	0.00116	CcSEcCtD
Topiramate—Thrombocytopenia—Docetaxel—head and neck cancer	0.000658	0.00116	CcSEcCtD
Topiramate—Tachycardia—Docetaxel—head and neck cancer	0.000656	0.00116	CcSEcCtD
Topiramate—Skin disorder—Docetaxel—head and neck cancer	0.000653	0.00115	CcSEcCtD
Topiramate—Anorexia—Docetaxel—head and neck cancer	0.000641	0.00113	CcSEcCtD
Topiramate—Diarrhoea—Fluorouracil—head and neck cancer	0.000637	0.00112	CcSEcCtD
Topiramate—Hypotension—Docetaxel—head and neck cancer	0.000628	0.00111	CcSEcCtD
Topiramate—Dizziness—Fluorouracil—head and neck cancer	0.000616	0.00109	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000612	0.00108	CcSEcCtD
Topiramate—Insomnia—Docetaxel—head and neck cancer	0.000608	0.00107	CcSEcCtD
Topiramate—Paraesthesia—Docetaxel—head and neck cancer	0.000604	0.00106	CcSEcCtD
Topiramate—Dyspnoea—Docetaxel—head and neck cancer	0.000599	0.00106	CcSEcCtD
Topiramate—Somnolence—Docetaxel—head and neck cancer	0.000598	0.00105	CcSEcCtD
Topiramate—Vomiting—Fluorouracil—head and neck cancer	0.000592	0.00104	CcSEcCtD
Topiramate—Dyspepsia—Docetaxel—head and neck cancer	0.000592	0.00104	CcSEcCtD
Topiramate—Rash—Fluorouracil—head and neck cancer	0.000587	0.00104	CcSEcCtD
Topiramate—Dermatitis—Fluorouracil—head and neck cancer	0.000587	0.00103	CcSEcCtD
Topiramate—Decreased appetite—Docetaxel—head and neck cancer	0.000584	0.00103	CcSEcCtD
Topiramate—Headache—Fluorouracil—head and neck cancer	0.000583	0.00103	CcSEcCtD
Topiramate—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00058	0.00102	CcSEcCtD
Topiramate—Fatigue—Docetaxel—head and neck cancer	0.00058	0.00102	CcSEcCtD
Topiramate—Pain—Docetaxel—head and neck cancer	0.000575	0.00101	CcSEcCtD
Topiramate—Constipation—Docetaxel—head and neck cancer	0.000575	0.00101	CcSEcCtD
Topiramate—Feeling abnormal—Docetaxel—head and neck cancer	0.000554	0.000977	CcSEcCtD
Topiramate—Nausea—Fluorouracil—head and neck cancer	0.000553	0.000976	CcSEcCtD
Topiramate—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00055	0.00097	CcSEcCtD
Topiramate—Abdominal pain—Docetaxel—head and neck cancer	0.000531	0.000937	CcSEcCtD
Topiramate—Body temperature increased—Docetaxel—head and neck cancer	0.000531	0.000937	CcSEcCtD
Topiramate—Hypersensitivity—Docetaxel—head and neck cancer	0.000495	0.000874	CcSEcCtD
Topiramate—Asthenia—Docetaxel—head and neck cancer	0.000482	0.000851	CcSEcCtD
Topiramate—Pruritus—Docetaxel—head and neck cancer	0.000476	0.000839	CcSEcCtD
Topiramate—Diarrhoea—Docetaxel—head and neck cancer	0.00046	0.000811	CcSEcCtD
Topiramate—Dizziness—Docetaxel—head and neck cancer	0.000445	0.000784	CcSEcCtD
Topiramate—Vomiting—Docetaxel—head and neck cancer	0.000427	0.000754	CcSEcCtD
Topiramate—Rash—Docetaxel—head and neck cancer	0.000424	0.000748	CcSEcCtD
Topiramate—Dermatitis—Docetaxel—head and neck cancer	0.000423	0.000747	CcSEcCtD
Topiramate—Headache—Docetaxel—head and neck cancer	0.000421	0.000743	CcSEcCtD
Topiramate—GRIA3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000399	0.00341	CbGpPWpGaD
Topiramate—Nausea—Docetaxel—head and neck cancer	0.000399	0.000704	CcSEcCtD
Topiramate—GRIK1—Neuronal System—HRAS—head and neck cancer	0.000398	0.00339	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—HRAS—head and neck cancer	0.000398	0.00339	CbGpPWpGaD
Topiramate—SCN1A—L1CAM interactions—MAPK1—head and neck cancer	0.00039	0.00333	CbGpPWpGaD
Topiramate—SCN1A—L1CAM interactions—EGFR—head and neck cancer	0.00039	0.00333	CbGpPWpGaD
Topiramate—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000375	0.0032	CbGpPWpGaD
Topiramate—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000371	0.00317	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—SOD2—head and neck cancer	0.000371	0.00316	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—AKT1—head and neck cancer	0.000368	0.00314	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—GPX1—head and neck cancer	0.000354	0.00302	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—STAT3—head and neck cancer	0.000342	0.00292	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—HRAS—head and neck cancer	0.000338	0.00288	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—HRAS—head and neck cancer	0.000337	0.00287	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000332	0.00283	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—MAPK3—head and neck cancer	0.000327	0.00279	CbGpPWpGaD
Topiramate—CA5A—Metabolism—NAT2—head and neck cancer	0.000324	0.00276	CbGpPWpGaD
Topiramate—CA6—Metabolism—NAT2—head and neck cancer	0.000324	0.00276	CbGpPWpGaD
Topiramate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000321	0.00274	CbGpPWpGaD
Topiramate—GRIA3—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000321	0.00273	CbGpPWpGaD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000318	0.00271	CbGpPWpGaD
Topiramate—CA9—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.000317	0.00271	CbGpPWpGaD
Topiramate—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000317	0.0027	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—MAPK1—head and neck cancer	0.000311	0.00265	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—MAPK1—head and neck cancer	0.000306	0.00261	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000304	0.00259	CbGpPWpGaD
Topiramate—CA7—Metabolism—NAT2—head and neck cancer	0.000302	0.00257	CbGpPWpGaD
Topiramate—CA5B—Metabolism—NAT2—head and neck cancer	0.000302	0.00257	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000295	0.00252	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000291	0.00248	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000291	0.00248	CbGpPWpGaD
Topiramate—SCN5A—L1CAM interactions—MAPK3—head and neck cancer	0.000288	0.00246	CbGpPWpGaD
Topiramate—CA6—Metabolism—DPYD—head and neck cancer	0.000284	0.00242	CbGpPWpGaD
Topiramate—CA5A—Metabolism—DPYD—head and neck cancer	0.000284	0.00242	CbGpPWpGaD
Topiramate—CA12—Metabolism—NAT2—head and neck cancer	0.00028	0.00239	CbGpPWpGaD
Topiramate—SCN5A—L1CAM interactions—MAPK1—head and neck cancer	0.000274	0.00234	CbGpPWpGaD
Topiramate—SCN5A—L1CAM interactions—EGFR—head and neck cancer	0.000274	0.00234	CbGpPWpGaD
Topiramate—CA5A—Metabolism—YAP1—head and neck cancer	0.000269	0.00229	CbGpPWpGaD
Topiramate—CA6—Metabolism—YAP1—head and neck cancer	0.000269	0.00229	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000265	0.00226	CbGpPWpGaD
Topiramate—CA7—Metabolism—DPYD—head and neck cancer	0.000265	0.00226	CbGpPWpGaD
Topiramate—CA5B—Metabolism—DPYD—head and neck cancer	0.000265	0.00226	CbGpPWpGaD
Topiramate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00026	0.00222	CbGpPWpGaD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000256	0.00218	CbGpPWpGaD
Topiramate—CA5B—Metabolism—YAP1—head and neck cancer	0.000251	0.00214	CbGpPWpGaD
Topiramate—CA7—Metabolism—YAP1—head and neck cancer	0.000251	0.00214	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—HRAS—head and neck cancer	0.00025	0.00213	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—HRAS—head and neck cancer	0.000246	0.00209	CbGpPWpGaD
Topiramate—CA12—Metabolism—DPYD—head and neck cancer	0.000245	0.00209	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—STAT3—head and neck cancer	0.000239	0.00204	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000239	0.00204	CbGpPWpGaD
Topiramate—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000239	0.00203	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000234	0.00199	CbGpPWpGaD
Topiramate—CA12—Metabolism—YAP1—head and neck cancer	0.000233	0.00198	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—MAPK3—head and neck cancer	0.000229	0.00195	CbGpPWpGaD
Topiramate—CA4—Metabolism—NAT2—head and neck cancer	0.000223	0.0019	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000223	0.0019	CbGpPWpGaD
Topiramate—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000221	0.00188	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—AKT1—head and neck cancer	0.000221	0.00188	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000219	0.00187	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—MAPK1—head and neck cancer	0.000218	0.00186	CbGpPWpGaD
Topiramate—CA2—Metabolism—NAT2—head and neck cancer	0.000214	0.00182	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000207	0.00176	CbGpPWpGaD
Topiramate—CA1—Metabolism—NAT2—head and neck cancer	0.000205	0.00175	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—NOTCH1—head and neck cancer	0.0002	0.0017	CbGpPWpGaD
Topiramate—CA4—Metabolism—DPYD—head and neck cancer	0.000196	0.00167	CbGpPWpGaD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000193	0.00165	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000192	0.00164	CbGpPWpGaD
Topiramate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00019	0.00162	CbGpPWpGaD
Topiramate—CA2—Metabolism—DPYD—head and neck cancer	0.000188	0.0016	CbGpPWpGaD
Topiramate—CA4—Metabolism—YAP1—head and neck cancer	0.000186	0.00158	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—MAPK1—head and neck cancer	0.000183	0.00156	CbGpPWpGaD
Topiramate—CA9—Metabolism—NAT2—head and neck cancer	0.00018	0.00154	CbGpPWpGaD
Topiramate—CA1—Metabolism—DPYD—head and neck cancer	0.00018	0.00153	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000179	0.00152	CbGpPWpGaD
Topiramate—CA2—Metabolism—YAP1—head and neck cancer	0.000178	0.00152	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000177	0.00151	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000176	0.0015	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000175	0.00149	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—HRAS—head and neck cancer	0.000175	0.00149	CbGpPWpGaD
Topiramate—CA1—Metabolism—YAP1—head and neck cancer	0.000171	0.00145	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—MAPK1—head and neck cancer	0.000168	0.00143	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000167	0.00143	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000167	0.00143	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—VEGFA—head and neck cancer	0.000164	0.0014	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—VEGFA—head and neck cancer	0.000164	0.0014	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—STAT3—head and neck cancer	0.000163	0.00139	CbGpPWpGaD
Topiramate—CA5A—Metabolism—TYMS—head and neck cancer	0.000162	0.00138	CbGpPWpGaD
Topiramate—CA6—Metabolism—TYMS—head and neck cancer	0.000162	0.00138	CbGpPWpGaD
Topiramate—CA6—Metabolism—GSTM1—head and neck cancer	0.00016	0.00136	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GSTM1—head and neck cancer	0.00016	0.00136	CbGpPWpGaD
Topiramate—CA9—Metabolism—DPYD—head and neck cancer	0.000158	0.00135	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000156	0.00133	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—MAPK3—head and neck cancer	0.000155	0.00132	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—MAPK3—head and neck cancer	0.000155	0.00132	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—AKT1—head and neck cancer	0.000154	0.00132	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GPX1—head and neck cancer	0.000153	0.0013	CbGpPWpGaD
Topiramate—CA6—Metabolism—GPX1—head and neck cancer	0.000153	0.0013	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000153	0.0013	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP1A1—head and neck cancer	0.000151	0.00129	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYP1A1—head and neck cancer	0.000151	0.00129	CbGpPWpGaD
Topiramate—CA5B—Metabolism—TYMS—head and neck cancer	0.000151	0.00129	CbGpPWpGaD
Topiramate—CA7—Metabolism—TYMS—head and neck cancer	0.000151	0.00129	CbGpPWpGaD
Topiramate—CA9—Metabolism—YAP1—head and neck cancer	0.00015	0.00128	CbGpPWpGaD
Topiramate—CA7—Metabolism—GSTM1—head and neck cancer	0.000149	0.00127	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GSTM1—head and neck cancer	0.000149	0.00127	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—MAPK1—head and neck cancer	0.000148	0.00126	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—MAPK1—head and neck cancer	0.000147	0.00126	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—EGFR—head and neck cancer	0.000147	0.00126	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—HRAS—head and neck cancer	0.000147	0.00125	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000146	0.00124	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000144	0.00123	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GPX1—head and neck cancer	0.000143	0.00122	CbGpPWpGaD
Topiramate—CA7—Metabolism—GPX1—head and neck cancer	0.000143	0.00122	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP1A1—head and neck cancer	0.000141	0.00121	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP1A1—head and neck cancer	0.000141	0.00121	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NOTCH1—head and neck cancer	0.000141	0.0012	CbGpPWpGaD
Topiramate—CA12—Metabolism—TYMS—head and neck cancer	0.00014	0.00119	CbGpPWpGaD
Topiramate—CA12—Metabolism—GSTM1—head and neck cancer	0.000138	0.00118	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000138	0.00118	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000136	0.00116	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000136	0.00116	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—HRAS—head and neck cancer	0.000135	0.00115	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000134	0.00115	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000134	0.00114	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000134	0.00114	CbGpPWpGaD
Topiramate—CA12—Metabolism—GPX1—head and neck cancer	0.000132	0.00113	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP1A1—head and neck cancer	0.000131	0.00112	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—MAPK1—head and neck cancer	0.000128	0.00109	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000126	0.00107	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—head and neck cancer	0.000124	0.00106	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000123	0.00105	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—UROD—head and neck cancer	0.000122	0.00104	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—HRAS—head and neck cancer	0.000118	0.00101	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VEGFA—head and neck cancer	0.000117	0.000997	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—STAT3—head and neck cancer	0.000116	0.000987	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VEGFA—head and neck cancer	0.000115	0.000982	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000115	0.00098	CbGpPWpGaD
Topiramate—CA4—Metabolism—TYMS—head and neck cancer	0.000111	0.00095	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MAPK3—head and neck cancer	0.000111	0.000943	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTM1—head and neck cancer	0.00011	0.000939	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MAPK3—head and neck cancer	0.000109	0.000929	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000107	0.000915	CbGpPWpGaD
Topiramate—CA2—Metabolism—TYMS—head and neck cancer	0.000107	0.000911	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTM1—head and neck cancer	0.000106	0.000901	CbGpPWpGaD
Topiramate—CA4—Metabolism—GPX1—head and neck cancer	0.000106	0.0009	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MAPK1—head and neck cancer	0.000105	0.000897	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EGFR—head and neck cancer	0.000105	0.000897	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP1A1—head and neck cancer	0.000104	0.000891	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MAPK1—head and neck cancer	0.000104	0.000884	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—EGFR—head and neck cancer	0.000104	0.000884	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—HRAS—head and neck cancer	0.000103	0.000878	CbGpPWpGaD
Topiramate—CA1—Metabolism—TYMS—head and neck cancer	0.000102	0.000874	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTM1—head and neck cancer	0.000101	0.000864	CbGpPWpGaD
Topiramate—CA2—Metabolism—GPX1—head and neck cancer	0.000101	0.000863	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000101	0.00086	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.0001	0.000857	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP1A1—head and neck cancer	0.0001	0.000854	CbGpPWpGaD
Topiramate—CA1—Metabolism—GPX1—head and neck cancer	9.7e-05	0.000827	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—MAPK1—head and neck cancer	9.63e-05	0.000821	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP1A1—head and neck cancer	9.6e-05	0.000819	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	9.43e-05	0.000804	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—HRAS—head and neck cancer	9.23e-05	0.000787	CbGpPWpGaD
Topiramate—CA9—Metabolism—TYMS—head and neck cancer	9.01e-05	0.000768	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTGS2—head and neck cancer	9.01e-05	0.000768	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTGS2—head and neck cancer	9.01e-05	0.000768	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTM1—head and neck cancer	8.9e-05	0.000759	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—MAPK1—head and neck cancer	8.81e-05	0.000751	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	8.77e-05	0.000747	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	8.65e-05	0.000737	CbGpPWpGaD
Topiramate—CA9—Metabolism—GPX1—head and neck cancer	8.53e-05	0.000727	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—HRAS—head and neck cancer	8.45e-05	0.00072	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP1A1—head and neck cancer	8.44e-05	0.00072	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTGS2—head and neck cancer	8.41e-05	0.000717	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTGS2—head and neck cancer	8.41e-05	0.000717	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—HRAS—head and neck cancer	8.32e-05	0.00071	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	8.31e-05	0.000708	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—head and neck cancer	8.22e-05	0.000701	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	8.2e-05	0.000699	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—STAT3—head and neck cancer	8.14e-05	0.000694	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—HRAS—head and neck cancer	8.07e-05	0.000688	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTEN—head and neck cancer	7.86e-05	0.00067	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTEN—head and neck cancer	7.86e-05	0.00067	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—head and neck cancer	7.79e-05	0.000664	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MAPK3—head and neck cancer	7.78e-05	0.000663	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—HRAS—head and neck cancer	7.73e-05	0.000659	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—MAPK1—head and neck cancer	7.7e-05	0.000656	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—head and neck cancer	7.46e-05	0.000636	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MAPK1—head and neck cancer	7.4e-05	0.000631	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EGFR—head and neck cancer	7.4e-05	0.000631	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTEN—head and neck cancer	7.33e-05	0.000625	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTEN—head and neck cancer	7.33e-05	0.000625	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—UROD—head and neck cancer	7.31e-05	0.000623	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—HRAS—head and neck cancer	7.07e-05	0.000603	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTEN—head and neck cancer	6.79e-05	0.000579	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—head and neck cancer	6.21e-05	0.00053	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—HRAS—head and neck cancer	6.18e-05	0.000527	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—head and neck cancer	5.96e-05	0.000508	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—HRAS—head and neck cancer	5.94e-05	0.000506	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—head and neck cancer	5.71e-05	0.000487	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CA—head and neck cancer	5.54e-05	0.000472	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CA—head and neck cancer	5.54e-05	0.000472	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTEN—head and neck cancer	5.42e-05	0.000462	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.36e-05	0.000457	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.31e-05	0.000452	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—head and neck cancer	5.25e-05	0.000447	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTEN—head and neck cancer	5.19e-05	0.000443	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CA—head and neck cancer	5.17e-05	0.000441	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CA—head and neck cancer	5.17e-05	0.000441	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NAT2—head and neck cancer	5.05e-05	0.00043	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—head and neck cancer	5.02e-05	0.000428	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTEN—head and neck cancer	4.98e-05	0.000425	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CA—head and neck cancer	4.79e-05	0.000409	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—head and neck cancer	4.53e-05	0.000386	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—head and neck cancer	4.53e-05	0.000386	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—DPYD—head and neck cancer	4.43e-05	0.000377	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTEN—head and neck cancer	4.38e-05	0.000373	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—head and neck cancer	4.23e-05	0.00036	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—head and neck cancer	4.23e-05	0.00036	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—YAP1—head and neck cancer	4.2e-05	0.000358	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—head and neck cancer	3.92e-05	0.000334	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CA—head and neck cancer	3.82e-05	0.000326	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CA—head and neck cancer	3.66e-05	0.000312	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CA—head and neck cancer	3.51e-05	0.0003	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.16e-05	0.000269	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—head and neck cancer	3.12e-05	0.000266	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CA—head and neck cancer	3.09e-05	0.000263	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NAT2—head and neck cancer	3.04e-05	0.000259	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—head and neck cancer	2.99e-05	0.000255	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—head and neck cancer	2.87e-05	0.000245	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.75e-05	0.000235	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—DPYD—head and neck cancer	2.66e-05	0.000227	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—YAP1—head and neck cancer	2.53e-05	0.000215	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—head and neck cancer	2.52e-05	0.000215	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TYMS—head and neck cancer	2.52e-05	0.000215	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.49e-05	0.000213	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPX1—head and neck cancer	2.39e-05	0.000204	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.36e-05	0.000201	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.94e-05	0.000166	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TYMS—head and neck cancer	1.52e-05	0.000129	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.5e-05	0.000128	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPX1—head and neck cancer	1.44e-05	0.000122	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.42e-05	0.000121	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.41e-05	0.00012	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTEN—head and neck cancer	1.23e-05	0.000104	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CA—head and neck cancer	8.65e-06	7.37e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—head and neck cancer	8.45e-06	7.2e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTEN—head and neck cancer	7.37e-06	6.28e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—head and neck cancer	7.06e-06	6.02e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.2e-06	4.43e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—head and neck cancer	4.25e-06	3.62e-05	CbGpPWpGaD
